94 related articles for article (PubMed ID: 23886194)
1. Steroid receptor coactivator-3 promotes bladder cancer through upregulation of CXCR4.
Zhang Y; Wang JH; Liu B; Qu PB
Asian Pac J Cancer Prev; 2013; 14(6):3847-50. PubMed ID: 23886194
[TBL] [Abstract][Full Text] [Related]
2. CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.
Shen HB; Gu ZQ; Jian K; Qi J
Tumour Biol; 2013 Jun; 34(3):1839-45. PubMed ID: 23526079
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.
Zhao W; Chang C; Cui Y; Zhao X; Yang J; Shen L; Zhou J; Hou Z; Zhang Z; Ye C; Hasenmayer D; Perkins R; Huang X; Yao X; Yu L; Huang R; Zhang D; Guo H; Yan J
J Biol Chem; 2014 Apr; 289(16):11219-11229. PubMed ID: 24584933
[TBL] [Abstract][Full Text] [Related]
4. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract][Full Text] [Related]
5. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.
Xu J; Wu RC; O'Malley BW
Nat Rev Cancer; 2009 Sep; 9(9):615-30. PubMed ID: 19701241
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.
Geng C; He B; Xu L; Barbieri CE; Eedunuri VK; Chew SA; Zimmermann M; Bond R; Shou J; Li C; Blattner M; Lonard DM; Demichelis F; Coarfa C; Rubin MA; Zhou P; O'Malley BW; Mitsiades N
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6997-7002. PubMed ID: 23559371
[TBL] [Abstract][Full Text] [Related]
7. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis.
Ma X; Xu L; Wang S; Cui B; Li X; Xu J; Ning G
J Hepatol; 2011 Aug; 55(2):445-52. PubMed ID: 21184786
[TBL] [Abstract][Full Text] [Related]
8. SRC-3 has a role in cancer other than as a nuclear receptor coactivator.
Ma G; Ren Y; Wang K; He J
Int J Biol Sci; 2011; 7(5):664-72. PubMed ID: 21647249
[TBL] [Abstract][Full Text] [Related]
9. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; O'Malley BW
Mol Endocrinol; 2011 Dec; 25(12):2041-53. PubMed ID: 22053001
[TBL] [Abstract][Full Text] [Related]
10. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
11. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator.
Labhart P; Karmakar S; Salicru EM; Egan BS; Alexiadis V; O'Malley BW; Smith CL
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1339-44. PubMed ID: 15677324
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
13. Differential recruitment of p160 coactivators by glucocorticoid receptor between Schwann cells and astrocytes.
Grenier J; Trousson A; Chauchereau A; Cartaud J; Schumacher M; Massaad C
Mol Endocrinol; 2006 Feb; 20(2):254-67. PubMed ID: 16179382
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-interacting protein suppresses bladder carcinogenesis.
Nishizawa K; Nishiyama H; Matsui Y; Kobayashi T; Saito R; Kotani H; Masutani H; Oishi S; Toda Y; Fujii N; Yodoi J; Ogawa O
Carcinogenesis; 2011 Oct; 32(10):1459-66. PubMed ID: 21771725
[TBL] [Abstract][Full Text] [Related]
15. SRC-3 is required for prostate cancer cell proliferation and survival.
Zhou HJ; Yan J; Luo W; Ayala G; Lin SH; Erdem H; Ittmann M; Tsai SY; Tsai MJ
Cancer Res; 2005 Sep; 65(17):7976-83. PubMed ID: 16140970
[TBL] [Abstract][Full Text] [Related]
16. iASPP is important for bladder cancer cell proliferation.
Liu T; Li L; Yang W; Jia H; Xu M; Bi J; Li Z; Liu X; Li Z; Jing H; Kong C
Oncol Res; 2011; 19(3-4):125-30. PubMed ID: 21473288
[TBL] [Abstract][Full Text] [Related]
17. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
Shah YM; Rowan BG
Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
[TBL] [Abstract][Full Text] [Related]
18. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.
Cavarretta IT; Mukopadhyay R; Lonard DM; Cowsert LM; Bennett CF; O'Malley BW; Smith CL
Mol Endocrinol; 2002 Feb; 16(2):253-70. PubMed ID: 11818499
[TBL] [Abstract][Full Text] [Related]
19. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
